Piperazine citrate
- Product NamePiperazine citrate
- CAS144-29-6
- CBNumberCB4258805
- MFC24H46N6O14
- MW642.65
- EINECS205-622-8
- MDL NumberMFCD00038961
- MOL File144-29-6.mol
- MSDS FileSDS
Chemical Properties
| Melting point | 183-187℃ |
| Boiling point | 208℃[at 101 325 Pa] |
| Density | 0.741[at 20℃] |
| vapor pressure | 56.928Pa |
| storage temp. | Inert atmosphere,Room Temperature |
| solubility | Soluble in DMSO |
| form | powder to crystal |
| color | White to Almost white |
| Water Solubility | 54g/L at 24℃ |
| Merck | 14,7464 |
| Major Application | pharmaceutical (small molecule) |
| InChI | InChI=1S/2C6H8O7.3C4H10N2/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;3*1-2-6-4-3-5-1/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);3*5-6H,1-4H2 |
| InChIKey | JDDHUROHDHPVIO-UHFFFAOYSA-N |
| SMILES | C(O)(C(=O)O)(CC(=O)O)CC(=O)O.C(CC(=O)O)(O)(C(=O)O)CC(=O)O.C1NCCNC1.C1NCCNC1.C1NCCNC1 |
| LogP | -1.15 |
| CAS DataBase Reference | 144-29-6(CAS DataBase Reference) |
| FDA UNII | RI85381D5G |
| EPA Substance Registry System | Piperazine, 2-hydroxy-1,2,3-propanetricarboxylate (3:2) (144-29-6) |
Safety
| Symbol(GHS) |
 
|
|||||||||
| Signal word | Danger | |||||||||
| Hazard statements | H317-H314-H319 | |||||||||
| Precautionary statements | P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P260-P264-P280-P301+P330+P331-P303+P361+P353-P363-P304+P340-P310-P321-P305+P351+P338-P405-P501-P264-P280-P305+P351+P338-P337+P313P | |||||||||
| Hazard Codes | Xi | |||||||||
| Risk Statements | 36/37/38 | |||||||||
| Safety Statements | 26 | |||||||||
| WGK Germany | 1 | |||||||||
| RTECS | TL3485000 | |||||||||
| TSCA | TSCA listed | |||||||||
| HS Code | 29335990 | |||||||||
| Storage Class | 8A - Combustible corrosive hazardous materials | |||||||||
| Hazard Classifications | Repr. 2 Resp. Sens. 1 Skin Corr. 1B Skin Sens. 1 | |||||||||
| NFPA 704: |
|
